Threshold crossing by the CDC in ABIONYX PHARMA

The Caisse des dépôts et consignations (CDC) has declared that it has crossed the threshold of 5% of voting rights in ABIONYX PHARMA. This declaration was received on December 10, 2024. On December 5, 2024, the CDC reached 7.34% of the company's voting rights, although it indirectly holds 4.67% of the capital. This situation results from the allocation of double voting rights to Bpifrance Participations, a subsidiary controlled by the CDC and EPIC Bpifrance.

Bpifrance Participations holds 1,630,451 shares of ABIONYX PHARMA, representing 3,260,902 voting rights. This underlines the importance of the role of the CDC in the shareholder structure of the company listed on Euronext Paris. The capital of ABIONYX is composed of 34,931,012 shares totaling 44,404,824 voting rights.